Medicare Enrolled
Dr. Traci Kimbrough, M.D.
Optician · Troy, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kimbrough from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kimbrough?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kimbrough
Dr. Traci Kimbrough is an optician specialist in Troy, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kimbrough performed 3,307 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Kimbrough received a total of $8,571 from 42 pharmaceutical and/or device companies across 448 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kimbrough is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 11% volume in MI
$8,571 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,307
Medicare services
Top 11% in MI for optician
Not available
Unique patients (not deduplicated)
$45
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
1,222 | $5 | $25 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
653 | $70 | $145 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
402 | $41 | $120 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
378 | $86 | $200 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
189 | $96 | $205 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
91 | $42 | $125 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
83 | $85 | $200 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
67 | $67 | $190 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
53 | $1 | $4 |
| Shaving of skin growth, 0.6-1.0 cm A minor procedure to shave off a skin growth on the body, arms, or legs that measures between 0.6 and 1.0 centimeters. |
41 | $88 | $220 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
23 | $39 | $85 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
22 | $131 | $240 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
21 | $130 | $305 |
| Skin growth shaving, 0.5 cm or less This procedure involves shaving off a small skin growth measuring 0.5 centimeters or less from the body, arms, or legs. |
20 | $54 | $185 |
| Shaving of skin growth on face, 0.6-1.0 cm This procedure involves shaving off a skin growth located on the face, ears, eyelids, nose, lips, or mouth. The size of the growth being removed is between 0.6 and 1.0 centimeters. |
15 | $106 | $210 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
14 | $104 | $240 |
| Shaving of skin growth, 0.6-1.0 cm A minor procedure to shave off a skin growth measuring 0.6 to 1.0 cm from the scalp, neck, hands, feet, or genitals. |
13 | $90 | $210 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$8,571
Total received (2018-2024)
Avg $1,224/year across 7 years
Top 12% in MI for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
448
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,207
2023
$1,444
2022
$751
2021
$752
2020
$759
2019
$1,506
2018
$1,152
Payments by company (2024)
Janssen Biotech, Inc.
$580
PFIZER INC.
$254
GENZYME CORPORATION
$207
ABBVIE INC.
$147
Amgen Inc.
$145
UCB, Inc.
$117
Regeneron Healthcare Solutions, Inc.
$106
Novartis Pharmaceuticals Corporation
$104
Incyte Corporation
$90
E.R. Squibb & Sons, L.L.C.
$88
Dermavant Sciences, Inc.
$83
SUN PHARMACEUTICAL INDUSTRIES INC.
$82
Lilly USA, LLC
$57
Kyowa Kirin, Inc.
$39
Arcutis Biotherapeutics, Inc.
$37
Boehringer Ingelheim Pharmaceuticals, Inc.
$34
Ortho Dermatologics, a division of Bausch Health US, LLC
$23
Organon Llc
$13
Top 3 companies account for 47.2% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$1,374
PFIZER INC.
$1,189
GENZYME CORPORATION
$677
Galderma Laboratories, L.P.
$644
Regeneron Healthcare Solutions, Inc.
$413
Ortho Dermatologics, a division of Bausch Health US, LLC
$400
Novartis Pharmaceuticals Corporation
$366
Amgen Inc.
$361
AbbVie, Inc.
$284
ABBVIE INC.
$263
UCB, Inc.
$211
Almirall LLC
$197
Sandoz Inc.
$185
AbbVie Inc.
$181
Biofrontera Inc.
$170
Dermavant Sciences, Inc.
$166
Incyte Corporation
$150
SUN PHARMACEUTICAL INDUSTRIES INC.
$142
Medtronic, Inc.
$137
Lilly USA, LLC
$117
LEO Pharma Inc.
$109
Sun Pharmaceutical Industries Inc.
$105
E.R. Squibb & Sons, L.L.C.
$88
Arcutis Biotherapeutics, Inc.
$88
Allergan Inc.
$68
Boehringer Ingelheim Pharmaceuticals, Inc.
$68
DUSA Pharmaceuticals, Inc.
$63
Janssen Scientific Affairs, LLC
$55
PruGen, Inc. Pharmaceuticals
$50
Kyowa Kirin, Inc.
$39
Aclaris Therapeutics, Inc.
$38
Celgene Corporation
$19
Mission Pharmacal Company
$18
Genentech USA, Inc.
$18
Bayer HealthCare Pharmaceuticals Inc.
$17
EPI Health, LLC
$15
NOVARTIS PHARMACEUTICALS CORPORATION
$15
Stemline Therapeutics Inc.
$15
TARO PHARMACEUTICALS USA, INC.
$14
Journey Medical Corporation
$14
Allergan, Inc.
$13
Organon Llc
$13
Top 3 companies account for 37.8% of all-time payments
Associated products mentioned in payments ›
20% · ABSORICA · ABSORICA (isotretinoin) · ADBRY · AKLIEF · ALTRENO · AMELUZ · ARAZLO · Ameluz · Avar · BLU-U · BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 · BOTOX · BOTOX COSMETIC · BRYHALI · Bimzelx · CIBINQO · COSENTYX · Cabtreo · Cimzia · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EFUDEX · ELZONRIS · ENSTILAR · EPIDUO FORTE · EUCRISA · Erivedge · Finacea · HADLIMA · HALOG · HUMIRA · Humira · ILUMYA · JUBLIA · KERYDIN · LITFULO · Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution · ONEXTON · OPZELURA · ORACEA · Otezla · Poteligeo · REMICADE · RETIN-A-MICRO · RHOFADE · RINVOQ · Repatha · SILIQ · SKYRIZI · SOOLANTRA · SPEVIGO · STELARA · Seysara · Sitavig · Skyrizi · Sotyktu · TALTZ · TREMFYA · TRILUMA · TargaDox · Tremfya · VENASEAL · VTAMA · Winlevi · XEPI · Zoryve
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Opticians in nearby ZIP areas
387
County median income
$95,296
Nearest hospital to ZIP centroid (approximate)
BEAUMONT HOSPITAL, TROY
2.9 mi
2.9 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kimbrough is a clinical cardiology specialist, with above-average Medicare volume (top 11% in MI), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kimbrough experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Kimbrough performed 1,222 destruction of precancerous skin growths, 2-14 services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Kimbrough receive payments from pharmaceutical companies?
Yes. Dr. Kimbrough received a total of $8,571 from 42 companies across 448 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kimbrough's costs compare to other opticians in Troy?
Dr. Kimbrough's average Medicare payment per service is $45. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kimbrough) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Troy
Browse opticians in Troy ranked by procedure volume and transparency data.
Highest volume
Top Opticians in MI
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in MI
Which MI opticians receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology